check_circleStudy Completed

Magnetic Resonance Angiography

Bayer Identifier:

90360

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Open, multicenter contrast-enhanced MRA study of body arteries using SH L 562 BB in comparison to i.a. DSA

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
179
Trial Dates
January 2000 - February 2001
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Gadavist/Gadovist (Gadobutrol, BAY86-4875)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Open, multicenter contrast-enhanced MRA study of body arteries using SH L 562 BB in comparison to i.a. DSA followed by blinded reader evaluation
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.